Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2010-10-31
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
wound dressing
The dressing is indicated for moderately to heavily exuding wounds such as venous leg ulcers.
Drawtex dressing
The dressing is indicated for moderately to heavily exuding wounds such as venous leg ulcers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Drawtex dressing
The dressing is indicated for moderately to heavily exuding wounds such as venous leg ulcers
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is attending weekly office visits at SW Wound Care Center as an out-patient.
* Subject has a moderately to highly exudative venous leg ulcer that would be indicated for treatment with Drawtex
* Subject or is informed about the trial, understands its nature of the study and provides written informed consent prior to study enrollment.
* Subject is willing and able to comply with all specified care and visit requirements
* Subject refuses to participate in the study.
* Subject already participates in the this study with one wound (only one wound per subject is allowed)
* Subject has known sensitivity to the trial product or any of its compounds.
* Subject is expected to be non-compliant.
* Subject's lesion is a primary skin cancer.
* Subject's lesion is the manifestation of a metastasis.
* Subject is pregnant.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beier Drawtex Healthcare, (PTY). Ltd
UNKNOWN
Southwest Regional Wound Care Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Randall Wolcott
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Randall D Wolcott, M.D.
Role: PRINCIPAL_INVESTIGATOR
Southwest Regional Wound Care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Southwest Regional Wound Care Center
Lubbock, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
56-RW-019
Identifier Type: -
Identifier Source: org_study_id